Buddha Basnyat is a medical doctor practicing medicine in Kathmandu, Nepal. His research interests are infectious disease (specifically typhoid, TB ) and high altitude illness both of which are common in South Asia ( population 1.9 billion, which includes Nepal).

He has published widely in both these fields in well-known medical journals and text books.

In 2022, largely based on the efficacy results of the typhoid conjugate vaccine study ( published in the NEJM in 2019, https://www.nejm.org/doi/full/10.1056/NEJMoa1905047,  in which he was the PI, the Nepali government with the help of GAVI ( Vaccine Alliance) administered the vaccine to 8 million Nepali children and included this vaccine in the annual vaccination schedule of Nepal.

He with his team just completed the largest typhoid treatment trial to date, and the publications of the results are eagerly awaited.

He is the Chair of The Oxford University Clinical Research Unit-Nepal, the Medical Director for the Travel and Mountain Medicine Center, and The Himalayan Rescue Association.

He is a Fellow of the American College of Physicians, Fellow of the Royal College of Physicians (Edinburgh).

He is the Honorary Consul for Canada in Nepal, since 2013.

Link to Google Scholar page for Buddha Basnyat for article citations: http://scholar.google.com/citations?user=jyidWzAPe6gC&hl=en